Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population.
机构:[1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.外科科室普通外科普通外五科(甲状腺疾病诊疗中心)昆明医科大学附属第一医院[2]Department of Ultrasound Imaging of The First Affiliated Hospital of Kunming Medical University, Kunming, China.医技科室医学影像中心超声科昆明医科大学附属第一医院
第一作者机构:[1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
通讯作者:
通讯机构:[1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.[*1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
推荐引用方式(GB/T 7714):
Liu Wen,Cao Weihan,Dong Zhizhong,et al.Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population.[J].ENDOCRINE PRACTICE.2022,28(4):391-397.doi:10.1016/j.eprac.2022.01.013.
APA:
Liu Wen,Cao Weihan,Dong Zhizhong&Cheng Ruochuan.(2022).Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population..ENDOCRINE PRACTICE,28,(4)
MLA:
Liu Wen,et al."Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population.".ENDOCRINE PRACTICE 28..4(2022):391-397